Company / Current Assets
Yubo International Biotech Ltd Current Assets History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$667.5K
FY2025
5-year range
$667.5K / $1.9M
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 4 consecutive years, from $2M in FY2020 to $667,512 in FY2025.
Based on SEC 10-K filings.
$667,512 in FY2025 with a 10-year CAGR of +46.2%.
Declined from $725,235 to $667,512 over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -3.8%
- 5-Year CAGR
- -19.0%
- 10-Year CAGR
- +46.2%
Key checks
Key Insights
- Yubo International Biotech Ltd's current assets has declined for 4 consecutive years.
- 5-year CAGR of -19.0%, indicating a declining trend.
- In FY2025, current assets decreased 2.2% year-over-year.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $667.5K | -2.2% |
| FY2024 | $682.8K | -5.9% |
| FY2023 | $725.2K | -3.3% |
| FY2022 | $750.0K | -60.7% |
| FY2020 | $1.9M | +47619.8% |
| FY2019 | $4.0K | -20.0% |
| FY2018 | $5.0K | +25.0% |
| FY2017 | $4.0K | -71.4% |
| FY2016 | $14.0K | -6.7% |
| FY2015 | $15.0K | +50.0% |